Shahariar Mohammed Fahim, PhD

Senior Research Lead, Evidence Synthesis

Shahariar joined ICER as a Research Lead in 2022, and was promoted to Senior Research Lead in 2024. He earned his doctoral degree in June 2022 from the Harrison College of Pharmacy, Auburn University. During his graduate studies, Shahariar was involved in a flagship project of the Center for Evidence based Policy (CEbP) for three consecutive years. This Drug Effectiveness Review Project (DERP) is a consortium of state Medicaid that pool their resources and contract certain services such as systematic reviews on medications of interest to guide policy decisions within their state. Shahariar participated in three large systematic reviews, two rapid reviews, and four topic briefs. These reviews and topic briefs were focused on different diseases as well as pharmaceutical treatments such as breast cancer, chronic myeloid leukemia, immunoglobulins, beta thalassemia, atopic dermatitis, and second-generation antipsychotics, etc. to serve the interests of the participating Medicaid administrators. Shahariar also participated in two large systematic reviews, facilitated by faculties and graduate students from 9 different academic institutions, focusing on the effects of diabetes self-management education on quality of life for persons with type 1 and type 2 diabetes. One of those systematic reviews was recently published in the Science of Diabetes Self-Management and Care journal.

In addition, Shahariar is an epidemiologist by training. He worked with several claims databases and national surveys to address research questions targeting overriding public health conditions such as cancer and diabetes. Shahariar is also interested in pharmacogenomics and completed the American Colleges of Clinical Pharmacy (ACCP) Academy Precision Medicine Certificate Program in 2020. In his spare time, Shahariar loves playing soccer.